The Hanover Appoints Richard W. Lavey Chief Operating Officer
Get Alerts THG Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.9%
EPS Growth %: -10.6%
Join SI Premium – FREE
Lavey will maintain his current responsibilities leading personal lines and core commercial, which includes the company's small and middle market businesses. He will also continue to lead the company's sales and distribution, corporate underwriting, marketing and risk solutions functions.
With more than 35 years of experience in the insurance and technology industries, Lavey brings a deep knowledge of The Hanover's business and distribution model as well as expertise in advancing strategy, leading business transformations, and galvanizing culture. Prior to joining The Hanover in 2004, Lavey was vice president of strategic initiatives for The
"We are very pleased to have Dick assume this key role in our organization and to have his leadership over our company's strategic operations," said
Lavey is a Phi Beta Kappa graduate of The College of the Holy Cross and earned his Master of Business Administration degree from Harvard Business School. He currently serves as Chair of the National Council on Compensation Insurance (NCCI).
For more information about The Hanover, please visit hanover.com.
About The Hanover
The Hanover Insurance Group, Inc. is the holding company for several property and casualty insurance companies, which together constitute one of the largest insurance businesses in
CONTACTS:
Emily P. Trevallion | Abby C. Ursoleo |
508-855-3263 | 508-855-3549 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-hanover-appoints-richard-w-lavey-chief-operating-officer-302420065.html
SOURCE The Hanover Insurance Group, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CSTS and Borussia Dortmund Partner to Bring 'EMMA' and Football Culture Closer to Chinese Fans
- NTT DATA Group Appoints Kazuhiko Nakayama as New President and Chief Executive Officer
- ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share